Speaker Profile
Ph.D., Chief Technology Officer, Myriad Genetics
Biography
Kevin R. Haas joined Myriad Genetics in May 2013. Previously, he was vice president of Bioinformatics. Today he is responsible for building Myriads precision medicine platform to improve the patient/provider experience through digital engagement, harnessing genetic data, and powering breakthrough products to serve millions of customers. Dr. Haas also serves on the Board of Directors and is vice president for USA Triathlon, the non-profit national governing body for the sport. Dr. Haas received a B.S. from University of Wisconsin-Madison and a Ph.D. in Chemical Engineering from University of California-Berkeley, where he worked on molecular simulation and machine learning to study protein dynamics from single molecule fluoresce. He has co-authored 16 peer reviewed publications and ten patent applications.
Session Abstract – PMWC 2023 Silicon Valley
Track Co-Chairs:
Russ Cucina, UCSF
- How can AI and Data Science Determine Which Patients should be Preemptively Tested? (PANEL)
Chair: Russ Cucina, UCSF
- Lisa Kroon, UCSF
- Sylvia Plevritis, Stanford
- Eran Segal, WI
- Daniel Knecht, CVS Health - Establishing Genomics in the Clinic as a Routine Requires AI and Automation
Chair: Bani Tamraz, UCSF
- Sergio Baranzini, UCSF
- James Shalaby, Elimu Informatics - Representation and Equity in Genomic Data
Chair: Karen Miga, UCSC
- Timothy Rebbeck, Harvard
- Keolu Fox, UC San Diego
- Malcolm John, UCSF - Overcoming Barriers to Bringing Multi-omic's into Clinical Practices
Chair: Russ Cucina, UCSF
- Peter DeVault, Epic
- Kevin Hass, Myriad
- Jim Chen, Tempus
- Amie Blanco, UCSF - Misaligned Incentives Across Public-Private Partnerships in Patient Health (PANEL)
Chair: Justin Wildsmith, Syntropy
- Steve Goldstein, UC Irvine
- Ken Harris, AWS
- Suzanne George, Dana Farber Cancer Institute
- Nelson D’Antonio, Palantir - From Code to the Clinic: A Framework for the Ethical Integration of Precision AI into Healthcare
- Lisa Lehmann, Google - PMWC Showcase:
- Thomas Westerling-Bui, Aiforia Inc.
- Amrie Grammer, Ampel Bio Solutions
- Liat Dassa, CytoReason
- Ryan Ahern, Truveta
